Based on baseline AFP and CRP levels, 228 HCC patients treated with Len-P were divided into CRAFITY 0 (n=66), CRAFITY 1 (n=100), and CRAFITY 2 (n=62) groups. The gene discussed is CRP; the disease is hepatocellular carcinoma.